Teva Thwarts UK Patent Challenge Against AZ’s Symbicor September 9, 2014 Teva is now free to market their version of the drug. Read More
Arthrex Lands $255 Million DOD Contract September 8, 2014 The Naples, Fla., company beat out 57 other contenders for the contract. Read More
Exelixis’ Cabozantinib Fails in Prostate Cancer Trial September 8, 2014 The drug is indicated for treating thyroid cancer. Read More
Veracyte Snaps Up Lung Cancer Test Maker Allegro for $21 Million September 5, 2014 Veracyte will launch Allegro’s lead lung cancer test in the second half of 2015. Read More
Court Denies Lilly, Takeda’s Request to Toss $9 Billion Damage Award in Bladder Cancer Case September 5, 2014 Experts say the verdict will likely be reduced. Read More
NICE Recommends MS Drug Tecfidera September 4, 2014 Biogen Idec said it will launch the drug within three months in England and Wales. Read More
Otoharmonics Gets FDA Green Light for Tinnitus Device September 4, 2014 The Levo System maps a patient’s tinnitus sounds, creating a customized aural therapy. Read More
Roche Rolls Out Cobas Testing Systems in CE Mark Countries September 3, 2014 The Cobas 6800 and 8800 systems can be used for a variety of testing purposes. Read More
Teva, AZ Want Nexium Conspiracy Lawsuit Tossed September 3, 2014 Companies argue that Teva couldn’t have marketed its version sooner due to approval delays plaguing Ranbaxy. Read More
Orgentec Diagnostika Acquires U.S. Diagnostic Test Maker Corgenix for $16 Million September 2, 2014 Together the two companies will offer more than 350 diagnostic tests. Read More
FDA Explains How Amendments May Affect PDUFA Timelines September 2, 2014 NDA, BLA or supplement amendments could affect the review timelines, the agency says. Read More
Nonin Medical's Finger Pulse Oximeter Clears FDA Hurdle August 29, 2014 The device measures oxygen saturation and pulse rate through a patient’s finger. Read More